Gray matter involvement predicts chemosensitivity and prognosis in gliomatosis cerebri

Neurology

Volumn 73, Issue 6, 2009, Pages 445-449

  Kaloshi, G ^a   Guillevin, R ^a   Martin Duverneuil, N ^a   Laigle Donadey, F ^a   Psimaras, D ^a   Marie, Y ^a   Mokhtari, K ^a   Hoang Xuan, K ^a,b   Delattre, J Y ^a,b   Sanson, M ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; NITROSOUREA; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROL GROUP; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; GLIOMATOSIS CEREBRI; GLIOSIS; GRAY MATTER; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REPEATED DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION; WHITE MATTER;

EID: 69449103956     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b163e2     Document Type: Article

References (15)

1. Sanson M, Cartalat-Carel S, Taillibert S, et al. Initial chemotherapy in gliomatosis cerebri. Neurology 2004;63:270-275.
2. Levin N, Gomori JM, Siegal T. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide. Neurology 2004;63:354-356. (Pubitemid 38971142)
3. Kaloshi G, Everhard S, Laigle-Donadey F, et al. Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri. Neurology 2008;70:590-595. (Pubitemid 351294636)
4. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 2004;22:3133-3138. (Pubitemid 41103727)
5. Everhard S, Kaloshi G, Criniere E, et al. MGMT methylation: a marker of response to temozolomide in low-grade gliomas. Ann Neurol 2006;60:740-743. (Pubitemid 46048490)
6. Swanson KR, Alvord EC, Jr., Murray JD. A quantitative model for differential motility of gliomas in grey and white matter. Cell Prolif 2000;33:317-329.
7. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39:235-250; discussion 250-1232 (Pubitemid 26251544)
8. Schiffer D, Cavalla P, Dutto A, Borsotti L. Cell proliferation and invasion in malignant gliomas. Anticancer Res 1997;17:61-69. (Pubitemid 27116646)
9. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, et al. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology 2004;63:2360-2362. (Pubitemid 40024350)
10. Zlatescu MC, TehraniYazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 2001;61:6713-6715. (Pubitemid 32896492)
11. Megyesi JF, Kachur E, Lee DH, et al. Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 2004;10:4303-4306. (Pubitemid 38878867)
12. Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 2006;129:1884-1891.
13. Jenkinson MD, Smith TS, Brodbelt AR, Joyce KA, Warnke PC, Walker C. Apparent diffusion coefficients in oligodendroglial tumors characterized by genotype. J Magn Reson Imaging 2007;26:1405-1412. (Pubitemid 350291266)
14. Jenkinson MD, Smith TS, Joyce KA, et al. Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumours. Neuroradiol 2006;48:703-713.
15. Mazzoleni S, Politi L, De Palma M, Galli R. EGFR expression identifies distinct populations of glioblastoma multiforme cancer stem cells with different tumorigenic potential. Abstracts for the Eighth Congress of the European Association for Neuro-Oncology (EANO). Neuro Oncol 2008;10(6):1109; P111.